clorazepate dipotassium has been researched along with Algodystrophic Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Franzke, HG; Skupin, G | 1 |
1 trial(s) available for clorazepate dipotassium and Algodystrophic Syndrome
Article | Year |
---|---|
[The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychosomatic syndromes (author's transl)].
Topics: Anti-Anxiety Agents; Autonomic Nervous System; Clinical Trials as Topic; Clorazepate Dipotassium; Depression; Drug Evaluation; Humans; Mental Fatigue; Migraine Disorders; Psychophysiologic Disorders; Reflex Sympathetic Dystrophy; Vascular Headaches | 1975 |